Objective 
Introduction

Pleural effusion is a common clinical problem in respiratory diseases and determining its etiology may be difficult because of the great variety of diseases that can elicit pleural effusion. Malignancy is a common cause as are benign diseases such as tuberculosis. Both benign and malignant effusions share the same lymphocytic exudative profile making it more difficult to determine a specific diagnosis. Furthermore, the differentiation between malignant and benign effusions is very important for further management plans.
Although cytological examination of the pleural fluid is a rapid, efficient and minimally invasive method of diagnosing cancer, the diagnostic yield is about 60% (1)
. Taking together these facts, the genetic analysis of pleural effusion may be useful for diagnosis and determining treatment strategies.
T a b l e 1 . T h e Ho mo z y g o u s De l e t i o n o f P 1 6 a n d Me t h o d s o f Di a g n o s i s i n 3 4 Ma l i g n a n t P l e u r a l E f f u s i o n
Since the multiple tumor suppressor gene1 (MTS1/p16) was reported by Kamb et al (3) 
E v a l u a t i o n o f s e n s i t i v i t y o f P CR f o r h o mo z y g o u s d e l e t i o n o f p 1 6 e x o n 2 g e n e . T h e DNA o f He p G2 c e l l s c o n t a i ni n g n o r ma l p 1 6 g e n e mi x e d wi t h A5 4 9 c e l l s c o n t a n i n g p 1 6 g e n e h o mo z y g o u s d e l e t i o n wa s e x t r a c t e d . P CR r e s u l t s s h o we d t h a t t h e h o mo z y g o u s d e l e t i o n wa s d e t e c t e d i n t h e 3 6 : 6 7 r a t i o o f He p G2 : A5 4 9 . A. P CR p r o d u c t s o f p 1 6 g e n e e x o n 2 ( 5 0 n g DNA) . B . P CR p r o d u c t s o f p 1 6 g e n e e x o n 2 ( 2 0 0 n g DNA) . C. P CR p r o d u c t s o f
Statistical analysis
Statistical analysis was performed using chi-square test. P <0.05 was considered as statistically significant.
Results
Analysis of the homozygous deletion of p16 gene
The PCR was performed by using 50 ng DNA extracted from pleural effusion as a template and CDK4 as an internal control. The sensitivity of PCR for p16 exon2 homozygous deletion was detected at a ration of 36 : 67 of HepG2 containing normal p16 gene and A549 containing homozygous deletion p16 gene (Fig. 1) (11, 12) . Therefore, some studies have attempted to increase the sensitivity of the cytological examination by using the determination of various tumor markers in pleural fluid and differentiate malignant from benign pleural fluid (13, 14) . Among them, CEA is the most commonly studied and used, with an accuracy in pleural fluid greater than that of other tumor markers (15) . Nevertheless, in almost all series on CEA in pleural fluid, high false positive results have been reported (16, 17) (3, (19) (20) (21) . Suppressed gene expression and inactivation of its function due to hypermethylation of the 5'-CpG island in the 5'-flanking region, and loss of heterozygosity or mutation were also reported (22) (23) (24) . Previous studies indicated that homozygous deletion was the main mechanism for inactivation of p16 gene in human primary lung carcinoma, especially in non-small cell lung carcinoma (23 
F i g u r e 2 . T h e a g a r o s e g e l e l e c t r o p h o r e s i s p i c t u r e o f t h e P CR a n a l y s i s o f t h e h o mo z y g o u s d e l e t i o n o f p 1 6 g e n e . A, P CR p r o d u c t s o f p 1 6 g e n e e x o n 2 . B , P CR p r o d u c t s o f CDK4 . C, t h e S o u t h e r n B l o t o f P CR p r o d u c t s p 1 6 g e n e . DNA s a mp l e f r o m v o l u n t e e r wh i t e b l o o d c e l l s ( 1 ) , t u b e r c u l o s i s p l e u r a l e f f us i o n ( 2 ) , n o DNA ( 3 ) , ma l i g n a n t p l e u r a l e f f u s i o n ( 4 -8 ) . M, 1 0 0 b p DNA l a d d e r .
T a b l e 2 . T h e Ae t i o l o g y a n d Ho mo z y g o u s De l e t i o n o f P 1 6 e x o n 2 o f P l e u r a l E f f u s i o n s was no obvious difference between the results of the homozygous deletion of p16 exon2 and the pleural fluid cytology. But the diagnostic sensitivity by combined methods was obviously higher than that of the homozygous deletion of
Discussion
Nearly all neoplasms have been reported to involve the pleura. In most studies, however, lung carcinoma has been the most common neoplasm, accounting for approximately one-third of all malignant effusions (1). The definitive diagnosis of malignant effusion is largely based on positive cytological and histological results but the sensitivity is only about 60%
. Thus, it is necessary to find a test with higher sensitivity in the diagnosis of malignant pleural effusions. Recently, genetic studies of pleural effusion have been reported (18). But the detection of p16 gene homozygous deletion in pleural fluid has not been reported to date. P16 gene, the well-known tumor suppressor gene, is located on chromosome 9p21, which is a frequent target of homozygous deletion in many tumor types. The proteins encoded by p16 gene inhibit progression through the G1 phase of the cell cycle and deletion or functional inactivation of p16 gene is expected to promote cell proliferation. Initial studies of p16 gene revealed homozygous deletions in many tumor lines
